Mount Sinai Researchers Overturn mRNA Vaccine Theory by Discovering Non-Immune Cells Shape Therapeutic Effectiveness

New research shows mRNA vaccines don't require dendritic cell expression and can be made more effective by avoiding the liver to boost T cell response.

By: AXL Media

Published: Apr 30, 2026, 8:17 AM EDT

Source: Information for this report was sourced from EurekAlert!

Rethinking the Biological Fundamentals of mRNA Vaccination

The scientific community has long operated under the assumption that the effectiveness of mRNA vaccines depends primarily on delivering genetic instructions directly to dendritic cells. These immune cells were thought to be the essential gatekeepers required to activate T cells and trigger a robust immune response. However, a groundbreaking study published in Nature Biotechnology by researchers at the Icahn School of Medicine at Mount Sinai has fundamentally challenged this framework. Senior author Brian D. Brown, PhD, notes that while dendritic cells remain important to the overall process, the direct delivery of mRNA to them is not a requirement for success.

The Surprising Role of Non-Immune Cells in Immune Priming

The research team discovered that non-immune cells, specifically those found in the liver and muscles, play a decisive role in shaping how the body responds to mRNA vaccines. Through a process known as cross-presentation, these non-immune cells produce the vaccine antigen and hand it off to the immune system. This shift in understanding suggests that the body's response is a more collaborative effort between different cell types than previously realized. By recognizing that non-immune cells act as active participants in the vaccination process, scientists have uncovered a new layer of biological complexity that can be exploited to design more potent therapies.

Utilizing MicroRNA Technology to Control Expression Locations

To test these interactions, the Mount Sinai team employed a novel technology involving microRNA target sites. These short genetic sequences act as molecular switches, allowing researchers to selectively "turn off" mRNA expression in specific organs or cell types. This precision tool enabled the investigators to isolate the effects of the vaccine in different parts of the body, such as the liver or muscle tissue. By precisely controlling where the mRNA-encoded protein is produced, the team was able to observe how different locations either amplified or suppressed the resulting immune response.